Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLEKHB2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | SLC35F5 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | NCL | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | RSL24D1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | KIAA1143 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | SASS6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | METRNL | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | CWC22 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RP11-101E3.5 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |